Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neutec inhaler ireland ltd. - ipratropium bromide monohydrate 0,522 mg - eq. ipratropium bromide 0,5 mg; salbutamol sulfate 3,012 mg - eq. salbutamol 2,5 mg - nebuliser solution - salbutamol and ipratropium bromide

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose; salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose - solution for inhalation - 500µg/2.5mg per dose - active: ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose excipient: purified water sodium chloride sulfuric acid - duolin is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg;  ; salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg - aerosol inhaler, metered dose - 0.02mg/0.1mg per dose - active: ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg   salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg excipient: heptafluoropropane lactose monohydrate - duolin hfa is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol - solution - 0.5 mg/2.5 ml - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous 0.5 mg/2.5 ml; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol 2.500 mg/2.5 ml

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - fenoterol hydrobromide; ipratropium bromide monohydrate 0.52mg/4ml eqv. to ipratropium bromide anhydrous - solution - 1.25 mg/4 ml - fenoterol hydrobromide 1.25 mg/4 ml; ipratropium bromide monohydrate 0.52mg/4ml eqv. to ipratropium bromide anhydrous 0.5 mg/4 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram - salbutamol and sodium cromoglicate

Ireland - English - HPRA (Health Products Regulatory Authority)

cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - salbutamol sulphate; ipratropium bromide monohydrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

azure pharmaceuticals ltd - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate